The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed‐ and random‐effects meta‐analyses
- 9 January 2006
- journal article
- research article
- Published by Wiley in American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics
- Vol. 141B (2), 149-154
- https://doi.org/10.1002/ajmg.b.30273
Abstract
Previously we derived independent estimates of the effect of the dopamine D2 receptor (DRD2) Ser311Cys polymorphism on risk for schizophrenia using fixed‐ and random‐effects meta‐analyses. Both analyses identified a significant association between the Cys allele and schizophrenia, but neither included all available data. Furthermore, genotype data were not evaluated in either analysis, thus precluding any determination of the mode of inheritance. The present study was conducted to resolve discrepancies between the existing meta‐analyses, and provide more comprehensive and accurate estimates of the nature and magnitude of the influence of the Ser311Cys polymorphism on risk for schizophrenia. All discrepancies between the two sets of previously meta‐analyzed studies were identified and resolved to the mutual satisfaction of the authors, and the final dataset was analyzed independently by fixed‐ and random‐effects meta‐analyses. A total of 27 samples, comprising 3,707 schizophrenia patients and 5,363 control subjects, were included in the analyses of allelic association, while smaller numbers of studies and subjects were included in each of the genotypic association analyses. A significant effect of the Cys allele was observed under both fixed‐effects (odds ratio [OR] = 1.4; P = 0.002) and random‐effects (OR = 1.4; P = 0.007) models. Cys/Ser heterozygotes were at elevated risk for schizophrenia when compared to Ser/Ser homozygotes (fixed‐ and random‐effects OR = 1.4, ps ≤ 0.005), but Cys/Cys homozygotes were at no elevated risk relative to heterozygotes (OR = 1.0, ps ≥ 0.948). There was no evidence of heterogeneity, excessive influence of any single study, or publication bias in any of the analyses, suggesting that the effect of this DRD2 polymorphism on schizophrenia risk is reliable and uniform across populations, and our estimates of its magnitude are robust and accurate.Keywords
This publication has 38 references indexed in Scilit:
- Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta‐analysisAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
- Delusional Disorder Molecular Genetic Evidence for Dopamine PsychosisNeuropsychopharmacology, 2002
- An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan populationPsychiatry and Clinical Neurosciences, 1997
- S311C D2DR variant: no association with schizophreniaThe Lancet, 1994
- Mismatch PCR RFLP Detection of DRD2 Ser311Cys Polymorphism and SchizophreniaBiochemical and Biophysical Research Communications, 1994
- Dopamine D2 receptor molecular variant and schizophreniaThe Lancet, 1994
- DRD2 Ser311/Cys311 polymorphism in schizophreniaThe Lancet, 1994
- No major role for the dopamine D2 receptor Ser → Cys311 mutation in schizophreniaPsychiatric Genetics, 1994
- A Structural Polymorphism of Human Dopamine D2 Receptor D2(Ser311 → Cys)Biochemical and Biophysical Research Communications, 1993